Filing Details

Accession Number:
0001628280-22-017186
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-06-15 10:24:07
Reporting Period:
2022-06-14
Accepted Time:
2022-06-15 10:24:07
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1398733 Aquestive Therapeutics Inc. AQST Pharmaceutical Preparations (2834) 208623253
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1739816 E. Peter Boyd C/O Aquestive Therapeutics, Inc.,
30 Technology Drive
Warren NJ 07059
Svp-Bus. Process & Info. Tech. No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-06-14 5,000 $0.81 59,532 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. This transaction was executed in multiple transactions at the price of $0.81. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and price at which the transaction was effected.